Resmed beats Q3 earnings and revenue estimates with strong margin gains, yet shares slip post earnings despite growth across ...
StockStory.org on MSN
RMD Q1 deep dive: Mask portfolio drives growth amid market uncertainty and new CFO appointment
Medical device company ResMed (NYSE:RMD) reported Q1 CY2026 results , with sales up 10.8% year on year to $1.43 billion. Its ...
17h
ResMed Inc (RMD) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions
ResMed Inc (RMD) reports an 11% revenue increase and strategic acquisition plans, while navigating supply chain challenges and competitive pressures.
Zacks Investment Research on MSN
ResMed (RMD) Reports Q3 Earnings: What Key Metrics Have to Say
For the quarter ended March 2026, ResMed (RMD) reported revenue of $1.43 billion, up 10.8% over the same period last year. EPS came in at $2.86, compared to $2.37 in the year-ago quarter. The reported ...
SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal third-quarter profit of $398.7 million. On a per-share basis, the San Diego-based company said it had profit of $2.74.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results